Development of acromegaly in a patient with anorexia nervosa: Pathogenetic and diagnostic implications

Journal of Endocrinological Investigation

Volumn 29, Issue 9, 2006, Pages 821-825

  de Menis, E ^a   Gola, M ^b   Giustina, A ^a,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Division of Medicine   (Italy)

^c SPEDALI CIVILI   (Italy)

Author keywords

Acromegaly; Anorexia nervosa; Galanin; Growth hormone; Neuroregulation; Pituitary tumor

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; LIOTHYRONINE; LUTEINIZING HORMONE; OCTREOTIDE; PROLACTIN; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

ACROMEGALY; ADULT; ANOREXIA NERVOSA; ARTICLE; BODY IMAGE; CASE REPORT; CORTICOTROPIN BLOOD LEVEL; EATING DISORDER; ENDOCRINE DISEASE; FEMALE; FOLLITROPIN BLOOD LEVEL; GROWTH HORMONE BLOOD LEVEL; HORMONE ACTION; HORMONE RESISTANCE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOPHYSIS ADENOMA; HYPOTHALAMUS; LIOTHYRONINE BLOOD LEVEL; LUTEINIZING HORMONE BLOOD LEVEL; MALNUTRITION; NEUROMODULATION; PATHOGENESIS; PROLACTIN BLOOD LEVEL; PROTEIN BLOOD LEVEL; PSYCHOSOMATIC DISORDER; SYMPATHETIC TONE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 33845335495     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347377     Document Type: Article

References (33)

1. Giustina A, Barkan A, Casanueva FF, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab 2000, 85: 526-9.
2. Douyon L, Schteingart D. Effect of obesity and starvation on thyroid hormone: growth hormone, and cortisol secretion. Endocrinol Metab Clin North Am 2002, 31: 173-89.
3. Tamai H, Mori K, Matsubayashi S, et al. Hypothalamic-pituitary-thyroidal dysfunctions in anorexia nervosa. Psychother Psychosom 1986, 46: 127-31.
4. Boyar R, Hellman L, Roffwarg H, et al. Cortisol secretion and metabolism in anorexia nervosa. N Engl J Med 1977, 296: 190-3.
5. Stoving R, Veldhuis J, Flyvbjerg A, et al. Jointly amplified basal and pulsatile growth hormone secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the growth hormone-insulin like growth factor-I axis. J Clin Endocrinol Metab 1999, 84: 2056-63.
6. Scacchi M, Pincelli A, Caumo A, et al. Spontaneous nocturnal growth hormone secretion in anorexia nervosa. J Clin Endocrinol Metab 1997, 82: 3225-9.
7. Argente J, Caballo N, Barrios V, et al. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation. J Clin Endocrinol Metab 1997, 82: 2084-92.
8. Misra M, Miller K, Bjornson J, et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab 2003, 88: 5615-23.
9. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998, 19: 717-97.
10. Casper RC, Davis JM, Pandey GN. The effect of the nutritional status and weight changes on hypothalamic function tests in anorexia nervosa. In: Vigerski RA ed. Anorexia Nervosa. New York: NY: Raven 1977, 137-47.
11. De Marinis L, Folli G, D'Amico C, et al. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa. J Clin Endocrinol Metab 1988, 66: 598-604.
12. Scacchi M, Pincelli AI, Cavagnini F. Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Frontiers in Neuroendocrinology 2003, 24: 200-24.
13. Shimon I, Melmed S. Genetic basis of endocrine disease. J Clin Endocrinol Metab 1997, 82: 1675-81.
14. Hanew K, Kokubun M, Sasaki A, Mouri T, Yoshinaga K. The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly. J Clin Endocrinol Metab 1980, 51: 292-7.
15. Biermasz NR, Smit JWA, van Dulken H, Roelfsema F. Postoperative persistent thyrotropin releasing hormone-induced growth hormone release predicts recurrence in patients with acromegaly. Clin Endocrinol (Oxf) 2002, 56: 313-9.
16. Swearingen B, Barker FG 2nd, Katznelson L, et al. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998, 83: 3419-26.
17. Biermasz NR, Van Dulken H, Roelfsema F. Ten-year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab 2000, 12: 4596-602.
18. Biermasz NR, Van Dulken H, Roelfsema F. Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. J Clin Endocrinol Metab 2000, 85: 2476-82.
19. Zirkee EJM, Corssmit EPM, Biermasz NR, et al. Pituitary magnetic resonance imaging is not required in the postoperative follow-up of acromegalic patients with long-term biochemical cure after transsphenoidal surgery. J Clin Endocrinol Metab 2004, 89: 4320-4.
20. Tatemoto K, Rokaeus A, Jornvall H, et al. Galanin - a novel biologically active peptide from porcine intestine. FEBS Lett 1983, 164: 124-8.
21. Rokaeus A. Galanin, a newly isolated biologically active neuropeptide. Trends Neurosci 1987, 10: 158-64.
22. Giustina A, Licini M, Schettino M, Doga M, Pizzocolo G, Negro-Vilar A. Physiologial role of galanin in the regulation of anterior pituitary function in humans. Am J Physiol 1994, 266: E57-61.
23. Giustina A, Girelli A, Bodini C, et al. Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. Horm Metab Res 1992, 24: 90-1.
24. Giustina A, Bussi AR, Conti C, et al. Comparative effect of galanin and pyridostigmine on the growth hormone response to growth hormone-releasing hormone in normal aged subjects. Horm Res 1992, 37: 165-70.
25. Giustina A, Girelli A, Bossoni S, Legati F, Schettino M, Wehrenberg WB. Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocrticoid treatment. Metabolism 1992, 41: 548-51.
26. Giustina A, Bresciani E, Bussi AR, et al. Characterization of the paradoxical growth hormone inhibitory effect of galanin in acromegaly. J Clin Endocrinol Metab 1995, 80: 1333-40.
27. Hulting AL, Land T, Berthold M, et al. Galanin receptors from human pituitary tumors assayed with human galanin as ligand. Brain Res 1993, 625: 173-6.
28. Kubota A, Yamada Y, Waser B, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 1994, 93: 1321-5.
29. 1) in culture. Life Sci 1994, 55: 1850-1.
30. Rolla M. The role of cholinergic pathways in eating disorders. Adv Biosci 1993, 90: 143-51.
31. Ghigo E, Arvat E, Gianotti L, et al. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. Biol Psychiatry 1994, 36: 689-95.
32. Stoving RK, Andersen M, Flyvbjerg A, et al. Indirect evidence for decreased hypothalamic somatostatinergic tone in anorexia nervosa. Clin Endocrinol (Oxf) 2002, 56: 391-6.
33. De Marinis L, Mancini A, Valle D, et al. Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa. Metabolism 2000, 49: 155-9.